TradingNote
Gurus

Top Investors

Warren BuffettCathie WoodLi LuRay DalioBill AckmanView all Top Investors
Archive
Industry

Technology & Software

Services-Prepackaged SoftwareComputer Programming & Data ProcessingView all Technology & Software
Research

NKGNW

NKGen Biotech, Inc. Warrants

Insider Trades

ActorHolding ValueLast TransactionAmountTransaction PriceCurrent Price
CNCFIC-2015 NV Family Investments, LLC10 Percent Owner
$5.0M39.3M shares
BuyMay 27, 2025
$5.0M39.3M shares
$0.1271
--
CNCFIC-2015 NV Family Investments, LLC10 Percent Owner
$2.8M21.8M shares
BuyMay 27, 2025
$2.5M19.7M shares
$0.1271
--
SPSong Paul Y.Chief Executive Officer
$5.3M41.7M shares
BuyMay 5, 2025
$5.3M41.7M shares
$0.1271
--
SPSong Paul Y.Chief Executive Officer
$2.7M21M shares
BuyMay 5, 2025
$2.6M20.8M shares
$0.1271
--
GAGraf Acquisition Partners IV LLC10 Percent Owner
$13M1.1M shares
OtherDec 20, 2024
$8.7M757.9k shares
$11.50
--
GAGraf Acquisition Partners IV LLC10 Percent Owner
$1.1M96.5k shares
OtherDec 20, 2024
$1.1M93.3k shares
$11.50
--
Trade NKGNW

About NKGen Biotech, Inc. Warrants

Established in 2021, Graf Acquisition Corp. IV is based in The Woodlands, Texas. This company currently conducts no major business operations; instead, its principal objective is to complete a strategic combination, such as a merger, acquisition of assets, stock exchange, or reorganization, with one or more existing businesses.

CEO
Paul Y. Song

Market Data

OpenThe first traded price for the current trading session.
$0.0012
HighThe highest traded price in the current trading session.
$0.0301
LowThe lowest traded price in the current trading session.
$0.0012
VolumeTotal shares traded during the current trading session.
100
52W HighThe highest traded price over the past 52 weeks.
$0.0301
52W LowThe lowest traded price over the past 52 weeks.
$0.0012

Valuation

Market CapCompany equity value based on share price multiplied by shares outstanding.
$6.2M
Enterprise ValueMarket cap plus debt and other claims, less cash and equivalents.
$46M

Financials

Free Cash FlowOperating cash flow minus capital expenditures from the latest annual cash flow statement.
$-21M
RevenueTotal sales from the latest annual income statement.
$0
Net IncomeProfit after expenses and taxes from the latest annual income statement.
$-44M
CashCash and equivalents, or cash plus short-term investments, from the latest balance sheet.
$0
DebtTotal debt from the latest balance sheet.
$0

Modern Market Industries

AI & Compute

  • Semiconductors & Accelerators
  • Cloud & AI Platforms
  • Data Center & Networking

Software & Digital

  • Enterprise Software
  • Cybersecurity
  • DevTools & Observability
  • Consumer Internet & Marketplaces
  • Digital Advertising & Media

Healthcare

  • GLP-1 & Metabolic Health
  • Biotech & Oncology
  • Medical Devices & Diagnostics
  • Healthcare Services
  • Pharmaceuticals

Finance & Energy

  • Banks & Capital Markets
  • Asset Management & Exchanges
  • Insurance
  • Payments & Fintech
  • Digital Assets
  • Oil, Gas & Fuels

Modern categories

  • AI & Compute Infrastructure
  • Software & Digital Platforms
  • Healthcare Innovation
  • Financial Infrastructure
  • Energy & Grid

Detailed industries

  • Semiconductors & Accelerators
  • Cloud & AI Platforms
  • Data Center & Networking
  • Enterprise Software
  • Cybersecurity
  • DevTools & Observability
  • Consumer Internet & Marketplaces
  • Digital Advertising & Media

Action types

  • Investor actions
  • Insider Trades
  • Congress Trades
  • Stocks

Browse

  • Archive
  • Industries
  • Categories
  • Investors
  • Watchlist
© 2026 TradingNote
ArchiveIndustriesCategoriesInvestorsWatchlist